[
  {
    "question": "Clear description of left 4th CN palsy, head tilted to the rt, asking where is the lesion in brain stem",
    "option_a": "(Trochlear lesions in the medulla) is anatomically inaccurate since the trochlear nucleus is not located in the medulla. Option b (Right rostral midbrain) is incorrect because a right",
    "option_b": "",
    "option_c": "(Left rostral midbrain) is correct given the decussation of the trochlear nerve fibers, which explains the presentation of left CN IV palsy with right head tilt.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "c",
    "subspecialty": "Other/Unclassified",
    "explanation": "The trochlear nerve (CN IV) uniquely emerges from the dorsal aspect of the rostral midbrain and decussates in the superior medullary velum. A lesion affecting these decussating fibers leads to an ipsilateral superior oblique muscle weakness but a contralateral head tilt due to compensatory mechanisms. In a left CN IV palsy stemming from a lesion in the left rostral midbrain, the decussating trochlear fibers are disrupted. This results in a failure of the left superior oblique muscle to function properly, causing vertical diplopia. The patient adopts a head tilt toward the right to compensate and minimize the diplopia. This decussation explains why the head tilt is contralateral to the side of the lesion. Clinically, patients with a unilateral trochlear nerve palsy present with vertical diplopia (which worsens on downgaze) and a compensatory head tilt away from the affected side. In this scenario, the left CN IV palsy with right head tilt localizes the lesion to the left rostral midbrain. Diagnosis is established by a detailed neuro-ophthalmologic examination, including cover tests and assessment of head posture. Differential diagnoses include other brainstem lesions and peripheral causes; however, the unique decussating anatomy of the trochlear nerve aids in distinguishing midbrain lesions from medullary or other brainstem pathologies. MRI of the brain is typically used to confirm the lesion localization. Management depends on the underlying cause. For isolated CN IV palsy due to demyelination (as in multiple sclerosis) or small midbrain infarcts, conservative management with prism glasses to correct diplopia or patching may be appropriate. In persistent or severe cases, strabismus surgery may be considered. In pregnant or lactating patients, non-surgical management is preferred, and if steroids are needed (for demyelinating causes), risks and benefits must be balanced. Option a (Trochlear lesions in the medulla) is anatomically inaccurate since the trochlear nucleus is not located in the medulla. Option b (Right rostral midbrain) is incorrect because a right-sided lesion would cause a head tilt toward the left. Option c (Left rostral midbrain) is correct given the decussation of the trochlear nerve fibers, which explains the presentation of left CN IV palsy with right head tilt. 1) The trochlear nerve is the only cranial nerve that decussates, meaning that a lesion on one side can produce contralateral compensatory signs. 2) Patients with CN IV palsy typically adopt a head tilt away from the affected side to minimize diplopia. Recent neuroimaging advances have improved the localization of brainstem lesions. Current guidelines recommend MRI evaluation in patients with isolated CN IV palsies to rule out demyelinating, vascular, or compressive etiologies, especially when the clinical presentation is atypical.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Clinical feature suggesto of rt MLF where is the lesion (impaired rt eye adduction, with left eye nystagmus on abduction)",
    "option_a": "(Right MLF) is correct because it directly explains the clinical findings: impaired adduction of the right eye and nystagmus of the left eye during abduction. Other options, such as a lesion in the right abducens nucleus or right oculomotor nerve, would lead to different clinical presentations (e.g., impaired abduction or additional deficits such as ptosis and pupillary involvement). A left MLF lesion would affect the left eye\u2019s ability to adduct, which is inconsistent with the presentation described.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Internuclear ophthalmoplegia (INO) is a disorder of conjugate horizontal gaze caused by a lesion in the medial longitudinal fasciculus (MLF). The MLF coordinates eye movements by linking the abducens nucleus to the contralateral oculomotor nucleus. In right INO, a lesion in the right MLF disrupts the neural transmission required for the right eye to adduct when looking to the left. Consequently, the right eye fails to adduct properly while the left eye, which is abnormally stimulated, exhibits nystagmus during abduction. This classic pattern arises because the intact left MLF still carries signals to its ipsilateral oculomotor nucleus, resulting in dysconjugate gaze. The hallmark of an INO is the presence of impaired adduction in the affected eye (in this case, the right eye) and nystagmus in the abducting eye (the left eye). Patients commonly report horizontal diplopia that becomes more pronounced on lateral gaze. INO is frequently seen in multiple sclerosis in younger patients and in stroke patients among the elderly. Diagnosis is made by clinical examination focusing on saccadic and pursuit eye movements. Differential diagnoses include cranial nerve III palsies, myasthenia gravis, and other brainstem pathologies. An MRI is the diagnostic modality of choice to confirm a lesion in the MLF. Management of INO is etiology-specific. In cases related to multiple sclerosis, high-dose corticosteroids for the acute relapse and initiation of disease modifying therapies are recommended. For vascular causes, management involves addressing underlying risk factors (e.g., hypertension, diabetes) and supportive care. In pregnant or lactating patients, treatment is individualized with consideration to fetal safety, with non-invasive management preferred when feasible. Option a (Right MLF) is correct because it directly explains the clinical findings: impaired adduction of the right eye and nystagmus of the left eye during abduction. Other options, such as a lesion in the right abducens nucleus or right oculomotor nerve, would lead to different clinical presentations (e.g., impaired abduction or additional deficits such as ptosis and pupillary involvement). A left MLF lesion would affect the left eye\u2019s ability to adduct, which is inconsistent with the presentation described. 1) INO is a key sign of a central demyelinating process in younger individuals and a vascular insult in older individuals. 2) The dissociated eye movements (adduction deficit with contralateral abducting nystagmus) must prompt evaluation for MLF lesions. Current neuroimaging techniques, especially high-resolution MRI, have enhanced the identification of MLF lesions. Ongoing research continues to elucidate the pathophysiological mechanisms in INO, with updated guidelines emphasizing prompt diagnosis and tailored management based on the underlying etiology.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Which of the following is the most common presentation of GCA",
    "option_a": "(AION) is correct. AION is the most common neuro",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Giant cell arteritis (GCA) is a granulomatous large-vessel vasculitis that predominantly affects patients older than 50 years. It involves the extracranial branches of the carotid artery (especially the temporal artery) and can lead to ischemic complications. One of the hallmark complications is anterior ischemic optic neuropathy (AION), the most common neuro-ophthalmic manifestation of GCA. In GCA, inflammatory infiltrates within the arterial wall lead to granulomatous inflammation, intimal thickening, and luminal narrowing. When the short posterior ciliary arteries are involved, the blood supply to the optic nerve head is compromised, resulting in ischemia. This ischemic injury manifests as AION with optic disc edema and sudden, painless vision loss. Patients typically present with systemic symptoms such as headache, jaw claudication, scalp tenderness, and elevated inflammatory markers (ESR and CRP). The sudden onset of painless vision loss in one eye, often accompanied by optic disc swelling on fundoscopic examination, strongly points toward AION secondary to GCA. Diagnostic evaluation includes a high clinical index of suspicion supported by laboratory findings of elevated ESR and CRP. Temporal artery ultrasound (with halo sign) and temporal artery biopsy remain key tools. Differential diagnoses include other causes of optic neuropathy (such as central retinal artery occlusion, posterior ischemic optic neuropathy, and optic neuritis), but these differ in age distribution, pain, and accompanying systemic features. Immediate high\u2010dose glucocorticoid therapy is the mainstay of treatment to prevent irreversible vision loss. First\u2010line management is with high-dose oral or intravenous steroids, especially if vision loss is imminent or has begun. Tocilizumab, an IL-6 receptor inhibitor, has emerged as a steroid-sparing agent in refractory cases. In pregnancy and lactation, glucocorticoids are generally considered safe when used at the lowest effective dose, though risk\u2013benefit discussions and close monitoring are essential. Option A (AION) is correct. AION is the most common neuro-ophthalmic presentation of GCA. Other options such as central retinal artery occlusion (CRAO) or posterior ischemic optic neuropathy (PION) may be encountered but are less frequent and differ in associated features; for example, optic neuritis is typically painful and seen in younger patients. 1. Prompt recognition and high-dose steroid treatment in suspected GCA is crucial to prevent bilateral vision loss. 2. Temporal artery biopsy remains the gold standard for diagnosis despite newer imaging techniques. 3. Elevated ESR/CRP levels are hallmark laboratory findings supporting the diagnosis. Recent guidelines from the American College of Rheumatology and EULAR emphasize early treatment with high-dose corticosteroids and the potential use of tocilizumab as an adjunct, especially in patients at risk for steroid-related complications. Temporal artery ultrasound is increasingly being recognized as a useful diagnostic adjunct.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Recurrent falls and abnormal Brain MRI with history of male affected in the family dx",
    "option_a": "(AION) is correct. AION is the most common neuro",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Giant cell arteritis (GCA) is a granulomatous large-vessel vasculitis that predominantly affects patients older than 50 years. It involves the extracranial branches of the carotid artery (especially the temporal artery) and can lead to ischemic complications. One of the hallmark complications is anterior ischemic optic neuropathy (AION), the most common neuro-ophthalmic manifestation of GCA. In GCA, inflammatory infiltrates within the arterial wall lead to granulomatous inflammation, intimal thickening, and luminal narrowing. When the short posterior ciliary arteries are involved, the blood supply to the optic nerve head is compromised, resulting in ischemia. This ischemic injury manifests as AION with optic disc edema and sudden, painless vision loss. Patients typically present with systemic symptoms such as headache, jaw claudication, scalp tenderness, and elevated inflammatory markers (ESR and CRP). The sudden onset of painless vision loss in one eye, often accompanied by optic disc swelling on fundoscopic examination, strongly points toward AION secondary to GCA. Diagnostic evaluation includes a high clinical index of suspicion supported by laboratory findings of elevated ESR and CRP. Temporal artery ultrasound (with halo sign) and temporal artery biopsy remain key tools. Differential diagnoses include other causes of optic neuropathy (such as central retinal artery occlusion, posterior ischemic optic neuropathy, and optic neuritis), but these differ in age distribution, pain, and accompanying systemic features. Immediate high\u2010dose glucocorticoid therapy is the mainstay of treatment to prevent irreversible vision loss. First\u2010line management is with high-dose oral or intravenous steroids, especially if vision loss is imminent or has begun. Tocilizumab, an IL-6 receptor inhibitor, has emerged as a steroid-sparing agent in refractory cases. In pregnancy and lactation, glucocorticoids are generally considered safe when used at the lowest effective dose, though risk\u2013benefit discussions and close monitoring are essential. Option A (AION) is correct. AION is the most common neuro-ophthalmic presentation of GCA. Other options such as central retinal artery occlusion (CRAO) or posterior ischemic optic neuropathy (PION) may be encountered but are less frequent and differ in associated features; for example, optic neuritis is typically painful and seen in younger patients. 1. Prompt recognition and high-dose steroid treatment in suspected GCA is crucial to prevent bilateral vision loss. 2. Temporal artery biopsy remains the gold standard for diagnosis despite newer imaging techniques. 3. Elevated ESR/CRP levels are hallmark laboratory findings supporting the diagnosis. Recent guidelines from the American College of Rheumatology and EULAR emphasize early treatment with high-dose corticosteroids and the potential use of tocilizumab as an adjunct, especially in patients at risk for steroid-related complications. Temporal artery ultrasound is increasingly being recognized as a useful diagnostic adjunct.",
    "exam_year": "2022",
    "exam_type": "Part II",
    "image_url": "page_30.png"
  },
  {
    "question": "Scenario oculomotor apraxia, spasticity, myoclonic seizure, hepatosplenomegally",
    "option_a": "(AION) is correct. AION is the most common neuro",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Other/Unclassified",
    "explanation": "Giant cell arteritis (GCA) is a granulomatous large-vessel vasculitis that predominantly affects patients older than 50 years. It involves the extracranial branches of the carotid artery (especially the temporal artery) and can lead to ischemic complications. One of the hallmark complications is anterior ischemic optic neuropathy (AION), the most common neuro-ophthalmic manifestation of GCA. In GCA, inflammatory infiltrates within the arterial wall lead to granulomatous inflammation, intimal thickening, and luminal narrowing. When the short posterior ciliary arteries are involved, the blood supply to the optic nerve head is compromised, resulting in ischemia. This ischemic injury manifests as AION with optic disc edema and sudden, painless vision loss. Patients typically present with systemic symptoms such as headache, jaw claudication, scalp tenderness, and elevated inflammatory markers (ESR and CRP). The sudden onset of painless vision loss in one eye, often accompanied by optic disc swelling on fundoscopic examination, strongly points toward AION secondary to GCA. Diagnostic evaluation includes a high clinical index of suspicion supported by laboratory findings of elevated ESR and CRP. Temporal artery ultrasound (with halo sign) and temporal artery biopsy remain key tools. Differential diagnoses include other causes of optic neuropathy (such as central retinal artery occlusion, posterior ischemic optic neuropathy, and optic neuritis), but these differ in age distribution, pain, and accompanying systemic features. Immediate high\u2010dose glucocorticoid therapy is the mainstay of treatment to prevent irreversible vision loss. First\u2010line management is with high-dose oral or intravenous steroids, especially if vision loss is imminent or has begun. Tocilizumab, an IL-6 receptor inhibitor, has emerged as a steroid-sparing agent in refractory cases. In pregnancy and lactation, glucocorticoids are generally considered safe when used at the lowest effective dose, though risk\u2013benefit discussions and close monitoring are essential. Option A (AION) is correct. AION is the most common neuro-ophthalmic presentation of GCA. Other options such as central retinal artery occlusion (CRAO) or posterior ischemic optic neuropathy (PION) may be encountered but are less frequent and differ in associated features; for example, optic neuritis is typically painful and seen in younger patients. 1. Prompt recognition and high-dose steroid treatment in suspected GCA is crucial to prevent bilateral vision loss. 2. Temporal artery biopsy remains the gold standard for diagnosis despite newer imaging techniques. 3. Elevated ESR/CRP levels are hallmark laboratory findings supporting the diagnosis. Recent guidelines from the American College of Rheumatology and EULAR emphasize early treatment with high-dose corticosteroids and the potential use of tocilizumab as an adjunct, especially in patients at risk for steroid-related complications. Temporal artery ultrasound is increasingly being recognized as a useful diagnostic adjunct.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Hyperammonemia, low Lcitrulline ?",
    "option_a": "(AION) is correct. AION is the most common neuro",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Giant cell arteritis (GCA) is a granulomatous large-vessel vasculitis that predominantly affects patients older than 50 years. It involves the extracranial branches of the carotid artery (especially the temporal artery) and can lead to ischemic complications. One of the hallmark complications is anterior ischemic optic neuropathy (AION), the most common neuro-ophthalmic manifestation of GCA. In GCA, inflammatory infiltrates within the arterial wall lead to granulomatous inflammation, intimal thickening, and luminal narrowing. When the short posterior ciliary arteries are involved, the blood supply to the optic nerve head is compromised, resulting in ischemia. This ischemic injury manifests as AION with optic disc edema and sudden, painless vision loss. Patients typically present with systemic symptoms such as headache, jaw claudication, scalp tenderness, and elevated inflammatory markers (ESR and CRP). The sudden onset of painless vision loss in one eye, often accompanied by optic disc swelling on fundoscopic examination, strongly points toward AION secondary to GCA. Diagnostic evaluation includes a high clinical index of suspicion supported by laboratory findings of elevated ESR and CRP. Temporal artery ultrasound (with halo sign) and temporal artery biopsy remain key tools. Differential diagnoses include other causes of optic neuropathy (such as central retinal artery occlusion, posterior ischemic optic neuropathy, and optic neuritis), but these differ in age distribution, pain, and accompanying systemic features. Immediate high\u2010dose glucocorticoid therapy is the mainstay of treatment to prevent irreversible vision loss. First\u2010line management is with high-dose oral or intravenous steroids, especially if vision loss is imminent or has begun. Tocilizumab, an IL-6 receptor inhibitor, has emerged as a steroid-sparing agent in refractory cases. In pregnancy and lactation, glucocorticoids are generally considered safe when used at the lowest effective dose, though risk\u2013benefit discussions and close monitoring are essential. Option A (AION) is correct. AION is the most common neuro-ophthalmic presentation of GCA. Other options such as central retinal artery occlusion (CRAO) or posterior ischemic optic neuropathy (PION) may be encountered but are less frequent and differ in associated features; for example, optic neuritis is typically painful and seen in younger patients. 1. Prompt recognition and high-dose steroid treatment in suspected GCA is crucial to prevent bilateral vision loss. 2. Temporal artery biopsy remains the gold standard for diagnosis despite newer imaging techniques. 3. Elevated ESR/CRP levels are hallmark laboratory findings supporting the diagnosis. Recent guidelines from the American College of Rheumatology and EULAR emphasize early treatment with high-dose corticosteroids and the potential use of tocilizumab as an adjunct, especially in patients at risk for steroid-related complications. Temporal artery ultrasound is increasingly being recognized as a useful diagnostic adjunct.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of mucormycosis with black nasal tx",
    "option_a": "(Amphotericin B) is correct because it is the gold",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a",
    "subspecialty": "Other/Unclassified",
    "explanation": "Mucormycosis is an aggressive, invasive fungal infection most commonly seen in immunocompromised patients (e.g., uncontrolled diabetics, especially those with ketoacidosis) and those with hematological malignancies. The disease tends to localize in the sinuses, brain, and orbit, and its hallmarks include rapid tissue invasion and necrosis. The causative organisms, Mucorales, invade blood vessels leading to thrombosis and tissue infarction. This vascular invasion underlies the rapid progression and necrotic features (e.g., black nasal tissue) seen in the infection. Early vascular invasion contributes to the high morbidity and mortality because it facilitates the spread to contiguous structures. Patients typically present with sinus pain, nasal congestion, and black, necrotic eschars on the nasal mucosa or palate. In advanced cases, extension into the orbit and brain may occur, manifesting as ophthalmoplegia, proptosis, or altered mental status. Recognition of the classic black necrotic tissue is crucial for early diagnosis. Diagnosis is based on clinical suspicion in high-risk patients, imaging (CT/MRI) to assess extent, and definitive histopathological confirmation with fungal staining and culture from debrided tissue. Differential diagnoses include invasive aspergillosis, bacterial necrotizing infections, and other causes of sinusitis; however, the presence of rapid progression and tissue necrosis favors mucormycosis. The first-line treatment is high-dose intravenous amphotericin B, typically in its liposomal formulation to reduce nephrotoxicity. Early initiation of antifungal therapy combined with aggressive surgical debridement is crucial. Second-line agents such as posaconazole or isavuconazole may be considered if there is intolerance or resistance. In pregnancy and lactation, amphotericin B is generally considered safe and remains the treatment of choice, with careful monitoring of maternal renal function and fetal well-being. Option a (Amphotericin B) is correct because it is the gold-standard treatment due to its broad spectrum and fungicidal action against Mucorales. Other antifungals such as voriconazole, fluconazole, or echinocandins (e.g., caspofungin) are ineffective against mucormycosis, and thus, incorrect. 1. Black necrotic tissue in the nasal cavity is almost pathognomonic for mucormycosis in high-risk patients. 2. Early aggressive treatment combining amphotericin B with surgical debridement significantly improves outcomes. 3. Liposomal amphotericin B is preferred due to its lower nephrotoxicity. Recent studies and updated clinical guidelines emphasize early diagnostic recognition and prompt initiation of liposomal amphotericin B. Surgical debridement is reaffirmed as a critical component of management, and newer azoles such as isavuconazole are being increasingly considered as salvage therapy.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Poor prognostic for brain abscess",
    "option_a": "(Decreased level of consciousness) is correct because it is a marker for more advanced disease and correlates with poor prognosis. Option b (Abscess near CSF spaces) is also correct given the heightened risk of rupture leading to life",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "a,b",
    "subspecialty": "Other/Unclassified",
    "explanation": "A brain abscess is a localized collection of pus within the brain parenchyma resulting from infection. Prognosis can be affected by several factors including the patient's neurological status and the anatomical location of the abscess. Poor prognostic factors, such as a decreased level of consciousness at presentation, suggest extensive brain involvement, raised intracranial pressure, or early signs of herniation. An abscess that is near CSF spaces increases the risk for rupture into the ventricular system or subarachnoid space, leading to complications like ventriculitis or meningitis. Clinically, patients with a brain abscess may present with headache, fever, focal neurological deficits, and altered consciousness. A decreased level of consciousness indicates severe parenchymal involvement and potential secondary complications. Abscesses located near CSF pathways are prone to rupture, causing rapid clinical deterioration. Diagnosis typically involves neuroimaging such as CT or MRI to localize the abscess. Differential diagnoses include neoplasms (e.g., gliomas), tuberculomas, or other intracranial space-occupying lesions. Lumbar puncture is generally avoided until mass effect is ruled out. The location and clinical context help differentiate a brain abscess from other intracranial lesions. Initial management relies on broad-spectrum intravenous antibiotics tailored to cover common bacterial pathogens. Surgical drainage or aspiration is often indicated, especially for abscesses larger than 2.5 cm or those causing significant mass effect. In patients with decreased LOC or abscesses near CSF spaces, early and aggressive management is imperative. In pregnancy and during lactation, antibiotic selections must be made with an emphasis on safety; options such as certain beta-lactams (e.g., penicillins and cephalosporins) are considered safe, although therapeutic decisions should balance maternal benefit and fetal exposure. Option a (Decreased level of consciousness) is correct because it is a marker for more advanced disease and correlates with poor prognosis. Option b (Abscess near CSF spaces) is also correct given the heightened risk of rupture leading to life-threatening complications. Both factors independently contribute to a worse outcome. 1. A decreased level of consciousness at presentation in brain abscess patients is a red flag indicating severe intracranial involvement. 2. Abscesses adjacent to CSF spaces are more likely to rupture, necessitating vigilant monitoring. 3. Early diagnosis and prompt, aggressive management are critical to improving outcomes. Recent reviews underscore that altered mental status is a significant prognostic indicator in brain abscess cases. Updated imaging techniques and treatment protocols continue to refine the diagnostic and therapeutic approaches, emphasizing multidisciplinary care.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "When to add metronidazole",
    "option_a": "(Mastoiditis) is correct because anaerobic pathogens are a known cause of complicated mastoiditis, making metronidazole a crucial addition to the treatment regimen. Other conditions that do not involve anaerobic infection would not benefit from metronidazole.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Mastoiditis is an infection of the mastoid air cells, usually a complication of acute or chronic otitis media. It often requires broad-spectrum coverage because the infection can be polymicrobial, including anaerobic organisms. In mastoiditis, infection spreads from the middle ear to the mastoid process, causing inflammation and potential abscess formation. Anaerobic bacteria may play a significant role in these cases, particularly in chronic or complicated infections, necessitating the use of metronidazole to cover these organisms. Patients with mastoiditis typically present with postauricular pain, swelling, fever, and tenderness over the mastoid region. The involvement of anaerobic pathogens can complicate the clinical course and may result in more severe infection if not appropriately managed. Diagnosis is based on clinical findings, supported by imaging studies such as CT of the temporal bone to assess the extent of mastoid involvement. Differential diagnoses include acute otitis media, cholesteatoma, and parotitis. Microbiological cultures may be taken to guide antibiotic therapy. Initial management includes broad-spectrum intravenous antibiotics that cover common aerobic pathogens (e.g., Streptococcus pneumoniae, Staphylococcus aureus). When there is suspicion or evidence of anaerobic infection, such as in complicated or chronic mastoiditis, metronidazole is added. In pregnancy and lactation, metronidazole is generally classified as category B; while caution is advised during the first trimester, its use may be justified when benefits outweigh potential risks, and it is considered acceptable during lactation. Option a (Mastoiditis) is correct because anaerobic pathogens are a known cause of complicated mastoiditis, making metronidazole a crucial addition to the treatment regimen. Other conditions that do not involve anaerobic infection would not benefit from metronidazole. 1. Always consider anaerobic coverage in cases of mastoiditis, especially if the infection is complicated or chronic. 2. Early imaging is key to evaluating the extent of infection. 3. Metronidazole should be used judiciously with consideration of patient-specific factors such as pregnancy and lactation. Recent guidelines from infectious diseases societies recommend the inclusion of anaerobic coverage in mastoiditis when indicated. Current research supports the early use of metronidazole in complicated mastoiditis to reduce complications and improve outcomes.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Fever meningismus mri showing left temporal hyperintensity",
    "option_a": "(CSF with RBC and lymphocytic pleocytosis) is correct because these CSF findings are typical for HSV encephalitis. Alternatives such as a bacterial profile (neutrophilic pleocytosis, low glucose) or normal CSF findings would not support the diagnosis.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "HSV encephalitis is the most common sporadic viral encephalitis in adults and children. It predominantly affects the temporal lobes, leading to a constellation of symptoms including fever, altered mental status, and focal neurological findings. Herpes simplex virus (HSV) invades the brain parenchyma, causing hemorrhagic necrosis particularly in the temporal and frontal lobes. This destructive process leads to inflammation, breakdown of the blood-brain barrier, and leakage of red blood cells (RBCs) into the cerebrospinal fluid (CSF). Patients typically present with fever, headache, seizures, focal neurological deficits, and behavioral changes. MRI findings of temporal lobe hyperintensities are highly characteristic. The presence of RBCs in the CSF, along with a lymphocytic pleocytosis, further supports the diagnosis of HSV encephalitis. The diagnosis is primarily based on clinical presentation, neuroimaging (MRI), and CSF analysis. Lumbar puncture typically reveals lymphocytic pleocytosis, elevated protein, and the presence of RBCs. Polymerase chain reaction (PCR) testing for HSV DNA in the CSF is the gold standard for confirming the diagnosis. Differential diagnoses include other viral encephalitides (e.g., VZV, CMV), autoimmune encephalitis, and brain abscess. Immediate initiation of intravenous acyclovir is critical, as early therapy has been shown to improve outcomes and reduce mortality. In pregnancy and lactation, acyclovir is considered safe; the benefits of prompt treatment in suspected HSV encephalitis far outweigh potential risks. The recommended duration of therapy is generally 14-21 days, with dosing adjusted based on renal function. Option a (CSF with RBC and lymphocytic pleocytosis) is correct because these CSF findings are typical for HSV encephalitis. Alternatives such as a bacterial profile (neutrophilic pleocytosis, low glucose) or normal CSF findings would not support the diagnosis. 1. Always consider HSV encephalitis in patients with fever, altered mental status, and temporal lobe abnormalities on MRI. 2. Early initiation of acyclovir is essential and can markedly improve patient outcomes. 3. CSF analysis with PCR confirmation is the diagnostic gold standard. Recent clinical guidelines and research emphasize the importance of early acyclovir treatment based on characteristic MRI and CSF findings. Advances in PCR diagnostics have improved the sensitivity and specificity of HSV detection, making prompt diagnosis and treatment more attainable.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Governmental clerk came with meningitis most common organism",
    "option_a": "(Pneumococcal) is correct because S. pneumoniae is the most common organism in adult community",
    "option_b": "(Meningococcal) is less likely in this patient demographic and setting, as meningococcal meningitis is more common among children, adolescents, and young adults, often in outbreak situations. Options c and d are not provided, so they cannot be considered.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Bacterial meningitis in adults is most commonly caused by Streptococcus pneumoniae (pneumococcus). It is the leading cause of community-acquired bacterial meningitis in adults, including individuals from various occupations such as government clerks. This organism has a polysaccharide capsule that contributes to its virulence and ability to evade the immune system. Streptococcus pneumoniae invades the bloodstream after colonizing the respiratory tract and eventually crosses the blood\u2013brain barrier. Once in the subarachnoid space, its cell wall components trigger a robust inflammatory response, leading to neuronal injury and increased intracranial pressure. The presence of pneumolysin and other virulence factors further exacerbate the host response. Current evidence underlines the rapid progression and high morbidity associated with pneumococcal meningitis. Patients typically present with fever, headache, neck stiffness, and altered mental status. In adults, and particularly in individuals without an epidemic outbreak setting, pneumococcal meningitis is statistically more likely than meningococcal meningitis. The absence of features such as a petechial rash, which is more characteristic of meningococcal presentations, further supports pneumococcal etiology in this patient. Diagnosis is primarily based on a lumbar puncture with analysis of the cerebrospinal fluid (CSF). Gram stain revealing Gram-positive diplococci and a culture confirming S. pneumoniae are diagnostic. Differential diagnoses include meningococcal meningitis (often with a characteristic rash), Listeria monocytogenes meningitis (especially in older adults or immunocompromised patients), and other bacterial causes. Radiologic studies and blood cultures can help differentiate between these conditions. Immediate empiric treatment is crucial. First-line therapy generally consists of intravenous vancomycin plus a third-generation cephalosporin (e.g., ceftriaxone), with adjunctive dexamethasone to reduce inflammatory complications, particularly in pneumococcal meningitis. For patients in pregnancy or lactation, cephalosporins and vancomycin are preferred due to their established safety profiles. Dexamethasone, however, should be used if the benefits outweigh risks\u2014current recommendations advise a case-by-case assessment. Option a (Pneumococcal) is correct because S. pneumoniae is the most common organism in adult community-acquired meningitis. Option b (Meningococcal) is less likely in this patient demographic and setting, as meningococcal meningitis is more common among children, adolescents, and young adults, often in outbreak situations. Options c and d are not provided, so they cannot be considered. 1. Streptococcus pneumoniae remains the most common cause of community-acquired bacterial meningitis in adults. 2. Early administration of empiric IV antibiotics and dexamethasone is critical to improve patient outcomes. 3. Lumbar puncture with prompt CSF analysis is essential for diagnosis. Recent studies and guidelines (such as those from the Infectious Diseases Society of America) consistently emphasize rapid initiation of empiric therapy in suspected pneumococcal meningitis. There is ongoing research into antibiotic resistance patterns which reinforces the importance of tailored therapy based on culture and sensitivity results.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Patient underwent decompression for chiari 2 weeks ago came with meningitis what is the most common organism",
    "option_a": "(Staphylococcal) is correct because postoperative meningitis is most commonly caused by organisms from the skin flora, particularly staphylococcal species. Option b (Pneumococcal) is incorrect since pneumococcal infection is more characteristic of community",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Postoperative meningitis, particularly following neurosurgical procedures like decompression surgery, is most commonly due to skin flora. Staphylococcal species, including Staphylococcus aureus and coagulase-negative staphylococci, are recognized as the predominant pathogens in these cases. During neurosurgical procedures, bacteria from the skin can contaminate the surgical field. These organisms, with a proclivity for biofilm formation especially on hardware or implanted materials, can later invade the meninges, triggering an inflammatory response. The timeline of infection (two weeks post-surgery) fits well with the typical incubation and postoperative contamination scenario. Patients who develop postoperative meningitis may present with symptoms such as fever, headache, and neck stiffness. The history of recent neurosurgery raises the index of suspicion for Staphylococcal involvement, as opposed to organisms like Streptococcus pneumoniae which are more common in community-acquired cases. Diagnosis requires CSF analysis via lumbar puncture, where Gram-positive cocci in clusters (indicative of staphylococci) may be observed. Differential diagnoses include community-acquired meningitis organisms like S. pneumoniae or, in some cases, Gram-negative organisms if there is a hardware infection. Repeat imaging and careful evaluation of any surgical site infections are also warranted. Initial empiric management includes broad-spectrum coverage with agents like vancomycin, targeting methicillin-resistant strains and other resistant staphylococci. Culture-directed therapy is essential once the organism is identified. In pregnant or lactating patients, vancomycin is generally considered safe, though dosing and monitoring are critical and must be tailored to the patient\u2019s clinical status. Option a (Staphylococcal) is correct because postoperative meningitis is most commonly caused by organisms from the skin flora, particularly staphylococcal species. Option b (Pneumococcal) is incorrect since pneumococcal infection is more characteristic of community-acquired meningitis. 1. Postoperative meningitis is often linked to skin flora contamination during surgery. 2. Early use of vancomycin is key in covering staphylococcal species. 3. Always consider recent surgical history when evaluating meningitis etiology. Recent guidelines reaffirm that the most common pathogens in postoperative meningitis are staphylococcal species. Clinical research continues to underscore the significance of early broad-spectrum antibiotic therapy, with subsequent tailoring based on culture results, to reduce morbidity and mortality in these cases.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Male Nurse exposed to pt with meningococcal meningitis what to do",
    "option_a": "(Give rifampin) is correct as it is the recommended prophylactic regimen for those exposed to Neisseria meningitidis. Option b (Immediate vaccination) is incorrect since vaccination does not provide immediate protection and immunity takes time to develop.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Neisseria meningitidis causes meningococcal meningitis\u2014a highly contagious infection transmitted via respiratory droplets. Post-exposure prophylaxis (PEP) is a key strategy in preventing secondary cases among close contacts, including healthcare workers. Meningococcal bacteria colonize the nasopharynx and can be shed in respiratory secretions. Rifampin is used for PEP because it effectively penetrates the nasopharyngeal tissue, eradicating the bacteria and interrupting transmission. In this scenario, a male nurse exposed to a patient with meningococcal meningitis is at risk of acquiring the infection due to close exposure to infectious secretions. Immediate prophylactic treatment reduces this risk significantly. While the focus here is on prophylaxis rather than diagnosis, confirmed meningococcal cases are typically diagnosed via CSF analysis using Gram stain, culture, or PCR. Differential considerations for PEP include close household contacts and other healthcare workers who may similarly be exposed. The first-line PEP agent is rifampin, administered according to established protocols. However, alternatives such as ciprofloxacin or intramuscular ceftriaxone may be preferred in certain populations. For pregnant or lactating women, ceftriaxone is often favored over rifampin due to its better safety profile in these groups. Option a (Give rifampin) is correct as it is the recommended prophylactic regimen for those exposed to Neisseria meningitidis. Option b (Immediate vaccination) is incorrect since vaccination does not provide immediate protection and immunity takes time to develop. 1. Post-exposure prophylaxis should be administered as soon as possible after exposure to reduce the risk of infection. 2. Rifampin is effective in eradicating nasopharyngeal carriage of meningococci. 3. Alternative agents should be considered for special populations, such as pregnant or lactating patients. Current CDC and WHO guidelines consistently recommend rifampin for meningococcal prophylaxis due to its rapid action in eradicating nasopharyngeal carriage. Ongoing research continues to evaluate alternative regimens for individuals with contraindications to rifampin.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Best tx to prevent post herpetic neuralgia",
    "option_a": "(Antiviral therapy) is correct because it directly targets the underlying viral replication, thereby reducing the nerve inflammation that contributes to PHN. Other options such as analgesics or corticosteroids may alleviate symptoms but do not effectively prevent the development of chronic neuropathic pain.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Postherpetic neuralgia (PHN) is a common complication of herpes zoster, resulting from reactivation of the varicella-zoster virus (VZV). Early antiviral therapy is central to reducing the risk of PHN by limiting viral replication and nerve damage. Herpes zoster occurs when latent VZV reactivates, typically in sensory ganglia, leading to inflammation and neuronal injury. Antiviral agents such as acyclovir, valacyclovir, or famciclovir reduce viral load if initiated within 72 hours of rash onset, thereby mitigating the intensity of the inflammatory response and subsequent nerve damage that leads to PHN. Patients with shingles typically exhibit a painful, unilateral, vesicular rash distributed along a dermatomal pattern. Initiation of antiviral therapy in the early stages can decrease both the duration of the acute phase and the likelihood of developing PHN. The diagnosis is primarily clinical, based on the presence of a characteristic rash and painful neuropathic symptoms. Differential diagnoses might include other causes of neuropathic pain such as diabetic neuropathy or post-surgical nerve injury, but the rash is pathognomonic for herpes zoster. First-line management to prevent PHN involves early administration of antiviral therapy (acyclovir, valacyclovir, or famciclovir) within 72 hours of rash appearance. These antivirals have demonstrated efficacy in reducing viral replication and subsequent neuronal damage. In pregnant or lactating patients, acyclovir is the preferred agent due to its well-established safety profile, though treatment should still be individualized based on patient risk factors and severity. Option a (Antiviral therapy) is correct because it directly targets the underlying viral replication, thereby reducing the nerve inflammation that contributes to PHN. Other options such as analgesics or corticosteroids may alleviate symptoms but do not effectively prevent the development of chronic neuropathic pain. 1. Initiate antiviral therapy ideally within 72 hours of rash onset to reduce the risk of PHN. 2. Acyclovir is widely used in practice due to its proven efficacy and safety profile in diverse populations. 3. Timely intervention can significantly lower long-term morbidity related to PHN. Recent meta-analyses and randomized controlled trials confirm that early antiviral therapy significantly lowers the incidence of PHN. Updated guidelines from neurology and infectious disease societies continue to advocate for this approach as the cornerstone of herpes zoster management.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario suggestive of SSPE, EEG attached showed periodic burst asking what to do next",
    "option_a": "(Brain MRI) is incorrect because although MRI may show cortical atrophy or white matter changes, these findings are nonspecific. Option B (Brain Biopsy) is invasive and unnecessary when less invasive tests (EEG plus CSF measles antibody assay) are definitive. Option C (Measles antibody) is correct since demonstrating elevated measles",
    "option_b": "",
    "option_c": "",
    "option_d": "is not provided.",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Other/Unclassified",
    "explanation": "Subacute sclerosing panencephalitis (SSPE) is a progressive, degenerative encephalitis that occurs years after an initial measles infection. Its diagnosis relies on both clinical features (behavioral changes, myoclonus, cognitive decline) and characteristic investigations. SSPE results from a persistent, mutated measles virus infection in the central nervous system. The virus causes demyelination and neuronal degeneration while provoking an intrathecal immune response that produces high levels of measles-specific antibodies. This chronic inflammation leads to the typical periodic EEG discharges observed in the disease. Patients typically present with subtle behavioral changes and cognitive decline that progress to myoclonic jerks and motor dysfunction. The classic periodic complexes on EEG, when combined with clinical features, strongly suggest SSPE. Relying on nonspecific tests like MRI may show white matter changes but do not confirm the diagnosis. Diagnosis is primarily based on the characteristic EEG pattern and confirmation with cerebrospinal fluid (CSF) and serum measles-specific antibody titers. While brain MRI can be supportive by revealing nonspecific white matter changes, and brain biopsy is invasive and reserved for atypical cases, the demonstration of elevated measles antibodies in CSF confirms intrathecal synthesis and the diagnosis. Currently, there is no cure for SSPE and management is mostly supportive. Some treatment protocols have explored the use of antiviral agents (e.g., isoprinosine) and immunomodulators, but with limited success. In pregnant or lactating patients, any experimental or off\u2010label use of antivirals must carefully balance potential teratogenic effects against benefits, with supportive care being the mainstay. Option A (Brain MRI) is incorrect because although MRI may show cortical atrophy or white matter changes, these findings are nonspecific. Option B (Brain Biopsy) is invasive and unnecessary when less invasive tests (EEG plus CSF measles antibody assay) are definitive. Option C (Measles antibody) is correct since demonstrating elevated measles-specific antibodies in the CSF is highly sensitive, specific, and noninvasive. Option D is not provided. \u2022 The combination of periodic EEG complexes and high CSF measles antibody titers is diagnostic for SSPE. \u2022 MRI findings are nonspecific and do not substitute for serologic confirmation. \u2022 Brain biopsy should be reserved for cases where diagnosis remains uncertain after noninvasive testing. Recent guidelines emphasize the definitive role of CSF measles antibody titers in diagnosing SSPE. Newer studies continue to show that while imaging may support the diagnosis, it cannot confirm it, and there remains no curative treatment\u2014highlighting the need for prevention through effective measles immunization.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Most common cause of polyradiculopathy, no mention of immune status",
    "option_a": "(CMV) is correct as it is the most common infectious cause of polyradiculopathy, particularly in patients with impaired immune function. Option B (TB) is less common and usually has a more chronic presentation with additional systemic features.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Polyradiculopathy is characterized by involvement of multiple nerve roots and can present with radicular pain, weakness, and sensory disturbances. Among infectious causes, certain viruses are known to cause direct inflammation of the nerve roots. Cytomegalovirus (CMV) can infect the nerve roots directly, leading to inflammation and demyelination. This is particularly common in immunocompromised individuals (e.g., those with HIV/AIDS), but may occasionally be seen in immunocompetent patients. The virus\u2019s ability to invade neural tissue results in an acute or subacute polyradiculopathy. Clinically, patients with CMV polyradiculopathy present with a rapid onset of radicular pain, motor deficits, and sometimes sensory loss. Unlike other granulomatous causes (like TB), CMV typically presents more acutely and is confirmed by detecting viral DNA in the CSF. The workup includes clinical evaluation, nerve conduction studies, and cerebrospinal fluid analysis with PCR testing for CMV DNA. Differential diagnoses include tuberculosis (typically a more insidious onset with systemic signs), Lyme disease, and autoimmune inflammatory neuropathies such as Guillain-Barr\u00e9 syndrome. First-line treatment is typically intravenous ganciclovir; foscarnet is considered as a second-line agent if resistance or intolerance occurs. When managing pregnant or lactating patients, clinicians must weigh the risk of potential teratogenic effects. Alternative supportive measures and careful monitoring are essential, as many antivirals have limitations in these populations. Option A (CMV) is correct as it is the most common infectious cause of polyradiculopathy, particularly in patients with impaired immune function. Option B (TB) is less common and usually has a more chronic presentation with additional systemic features. \u2022 CMV infection should be suspected in patients with acute polyradiculopathy, especially in immunocompromised individuals. \u2022 CSF PCR for CMV DNA is a critical and sensitive diagnostic tool. \u2022 Early antiviral therapy can improve outcomes. Recent research emphasizes the high diagnostic yield of CSF PCR in detecting CMV. Guidelines continue to support the use of IV ganciclovir as the standard of care while also highlighting the necessity for caution when treating special populations such as pregnant or breastfeeding women.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Patient has confusion, lymphadenopathy and flaccid paralysis what is the organism",
    "option_a": "(West Nile Virus) is correct because it is the only pathogen among the options that typically causes both confusion (encephalopathy) and flaccid paralysis due to anterior horn cell involvement. Option B (Herpes Simplex Virus) usually presents as focal temporal lobe encephalitis with seizures, and Option C (Poliovirus) typically causes flaccid paralysis without significant encephalopathy.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "West Nile Virus (WNV) is an arthropod-borne (mosquito-transmitted) flavivirus that can cause neuroinvasive disease in a subset of infected individuals. In cases of neuroinvasive WNV, the virus breaches the blood\u2013brain barrier and infects neurons in the central nervous system. The involvement of anterior horn cells can lead to a poliomyelitis-like syndrome with acute flaccid paralysis, while concurrent meningoencephalitis may lead to confusion and other altered mental status features. Lymphadenopathy may also be present due to systemic viral replication. Patients with WNV neuroinvasive disease commonly present with fever, headache, and altered mental status (confusion). The development of acute flaccid paralysis is an important clinical clue that suggests involvement of the anterior horn cells, differentiating it from other viral encephalitides. The diagnosis is made based on clinical suspicion, supported by laboratory testing: serum and CSF analysis for WNV-specific IgM antibodies, and sometimes PCR in the early phase. Important differential diagnoses include herpes simplex virus encephalitis (which characteristically affects the temporal lobes) and poliovirus (which rarely causes encephalitis in the post-vaccination era). There is no specific antiviral treatment for WNV. Management is supportive, focusing on respiratory support, hemodynamic stabilization, and rehabilitation when needed. In pregnant or lactating patients, supportive care remains the cornerstone of treatment, as none of the available experimental treatments have proven efficacy or established safety profiles in these populations. Option A (West Nile Virus) is correct because it is the only pathogen among the options that typically causes both confusion (encephalopathy) and flaccid paralysis due to anterior horn cell involvement. Option B (Herpes Simplex Virus) usually presents as focal temporal lobe encephalitis with seizures, and Option C (Poliovirus) typically causes flaccid paralysis without significant encephalopathy. \u2022 West Nile Virus should be suspected during mosquito season in patients presenting with acute flaccid paralysis and encephalopathy. \u2022 Detection of WNV-specific IgM antibodies in serum or CSF helps confirm the diagnosis. \u2022 Supportive care is the mainstay of management in the absence of approved antiviral therapy. Recent epidemiological studies have reinforced the significance of early diagnosis via serologic testing. Ongoing research continues to explore potential antiviral therapies, but current standard care remains supportive.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "A 44-year-old man is evaluated for visual loss. Examination shows a right homonymous hemianopia with a relative afferent pupillary defect in the right eye. Which of the following is the most likely location of the lesion?",
    "option_a": "junction between left optic nerve and chiasm",
    "option_b": "lateral fibers of the right optic nerve",
    "option_c": "left lateral geniculate nucleus",
    "option_d": "left occipital cortex",
    "option_e": "left optic tract",
    "correct_answer": "E",
    "subspecialty": "Other/Unclassified",
    "explanation": "The visual pathway extends from the retina to the occipital cortex, and lesions at different levels produce distinct visual field deficits. A homonymous hemianopia indicates a lesion beyond the optic chiasm, affecting the contralateral visual field. A lesion in the left optic tract interrupts the transmission of visual information from the nasal retina of the right eye and the temporal retina of the left eye, resulting in a right homonymous hemianopia. In some cases, the asymmetrical loss of afferent fibers can produce a relative afferent pupillary defect (RAPD) in the eye contributing more fibers to the damaged tract. The patient\u2019s presentation of a right homonymous hemianopia localizes the lesion to the left retrochiasmal pathway. The presence of an RAPD, particularly in the right eye, suggests a significant loss of afferent input from that eye, which is consistent with a lesion of the left optic tract where fibers from the right nasal retina are affected. Evaluation includes detailed visual field testing and neuro-ophthalmologic examination. Neuroimaging, preferably high-resolution MRI, is used to localize the lesion. Differential diagnoses for a contralateral homonymous hemianopia include lesions of the lateral geniculate nucleus (LGN) and the occipital cortex; however, these locations typically do not produce an RAPD because the pupillary light reflex pathway is less affected. Management depends on the underlying cause of the lesion (e.g., infarction, demyelination, neoplasm). For instance, if a vascular event is suspected, acute management with stroke protocols is initiated. In the context of demyelinating disease, corticosteroids may be used. In pregnant or lactating women, treatment should balance maternal and fetal risks with preferences for modalities (like MRI without contrast) that minimize exposure to potential teratogens. Option A (junction between left optic nerve and chiasm) is more likely to produce a junctional scotoma with an incongruous defect, rather than a complete homonymous hemianopia with RAPD. Option B (lateral fibers of the right optic nerve) would yield a monocular defect. Option C (left lateral geniculate nucleus) and Option D (left occipital cortex) typically do not result in an RAPD since the afferent pathway remains largely intact. Option E (left optic tract) best explains both the homonymous hemianopia and the presence of an RAPD in the right eye. \u2022 A homonymous hemianopia localizes the lesion to the retrochiasmal visual pathway. \u2022 An RAPD in a homonymous hemianopia setting suggests involvement of the optic tract rather than cortical areas. \u2022 Detailed neuro-ophthalmologic examination coupled with high-resolution MRI is essential for accurate localization. Contemporary neuro-ophthalmologic literature supports that subtle RAPDs can occur with optic tract lesions due to asymmetric fiber involvement. High-resolution MRI remains the gold standard for lesion localization and diagnosis, with ongoing research refining the nuances of visual pathway disorders.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Hallucination where is the lesion",
    "option_a": "(Midbrain) is correct because peduncular hallucinosis is most typically associated with lesions in the midbrain peduncular region. Alternative sites such as the occipital lobe (which often produces simple or elementary hallucinations with associated visual field deficits), temporal lobe (seen in temporal lobe epilepsy with brief hallucinations), or parietal lobe (less commonly linked to visual hallucinations) are less consistent with the described syndrome. Psychiatric causes lack a clear anatomical lesion and generally present with auditory hallucinations rather than the complex, formed visual hallucinations seen here.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Other/Unclassified",
    "explanation": "Peduncular hallucinosis refers to complex, vivid visual hallucinations that typically occur due to lesions in the midbrain, particularly around the cerebral peduncle region. This syndrome is characterized by the presence of formed, often colorful images with preserved insight. Lesions in the midbrain disrupt normal inhibitory control mechanisms and the integration of visual processing pathways. Damage in the peduncular area can lead to disinhibition of visual association cortices, resulting in vivid hallucinations. The neural circuits normally moderating sensory inputs become altered, leading to abnormal visual perceptions despite intact primary vision. Patients with peduncular hallucinosis often present with complex visual hallucinations in the absence of significant cognitive impairment or primary visual loss. These hallucinations may be triggered by brainstem strokes, tumors, or other vascular lesions affecting the midbrain. The preservation of insight is a hallmark that helps differentiate this syndrome from primary psychiatric disorders. Diagnosis is primarily clinical, supported by neuroimaging. Differential diagnoses include occipital lobe lesions (which tend to cause simpler visual hallucinations and are usually associated with visual field deficits), temporal lobe epilepsy (brief, stereotyped hallucinations), and psychiatric conditions. Magnetic resonance imaging (MRI) focusing on the midbrain region is the imaging modality of choice. Management involves addressing the underlying cause of the midbrain lesion (e.g., treating a stroke, removing a tumor, or managing vascular risk factors). Symptomatic treatment might include low-dose antipsychotics; however, these must be selected with caution. In pregnant or lactating patients, medications with acceptable safety profiles (e.g., those categorized as safe by current teratogenic risk guidelines) should be chosen, and multidisciplinary consultation is advisable. Option A (Midbrain) is correct because peduncular hallucinosis is most typically associated with lesions in the midbrain peduncular region. Alternative sites such as the occipital lobe (which often produces simple or elementary hallucinations with associated visual field deficits), temporal lobe (seen in temporal lobe epilepsy with brief hallucinations), or parietal lobe (less commonly linked to visual hallucinations) are less consistent with the described syndrome. Psychiatric causes lack a clear anatomical lesion and generally present with auditory hallucinations rather than the complex, formed visual hallucinations seen here. 1. Peduncular hallucinosis typically presents with vivid, formed visual hallucinations but preserved insight. 2. Lesions in the midbrain peduncular area can disrupt normal visual processing without causing primary visual loss. Recent studies using advanced neuroimaging have reinforced the role of the midbrain in visual integration and clarified that disruptions in inhibitory pathways\u2014particularly in the peduncular region\u2014are critical in the pathogenesis of peduncular hallucinosis. Updated reviews in neuro-ophthalmology continue to support midbrain lesions as the source of these unique symptoms.",
    "exam_year": "2022",
    "exam_type": "Part II"
  },
  {
    "question": "Male with sensory motor axonal neuropathy, decrease pain, temp, and vibration, family hx",
    "option_a": "(RET): RET mutations are associated with conditions like multiple endocrine neoplasia type 2 and Hirschsprung disease, not HSAN type I. \n\u2022 Option B (SPTLC): This is correct as mutations in the SPTLC genes are the established cause of HSAN type I. \n\u2022 Option C (TRKA): Mutations in the NTRK1 gene, which encodes the TRKA receptor, cause congenital insensitivity to pain with anhidrosis (HSAN IV), a condition distinguishable by its early onset and lack of motor involvement. \n\u2022 Option D (IKAP): Mutations in the ELP1 gene (IKAP) cause familial dysautonomia (HSAN III), which primarily features autonomic dysfunction and has a distinct ethnic prevalence.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Other/Unclassified",
    "explanation": "Hereditary Sensory and Autonomic Neuropathies (HSAN) represent a group of genetic disorders characterized by progressive degeneration of sensory and, in some cases, motor axons. HSAN type I, often associated with mutations in genes encoding components of sphingolipid metabolism, typically presents in adulthood with loss of pain, temperature, and vibration sensation along with a variable degree of motor involvement. Mutations in the SPTLC gene (including SPTLC1 and SPTLC2) result in altered function of serine palmitoyltransferase, the rate-limiting enzyme in sphingolipid synthesis. This leads to the accumulation of atypical deoxysphingolipids, which are neurotoxic to peripheral sensory and motor neurons. The resultant axonal degeneration contributes to the characteristic sensory and motor deficits seen in HSAN type I. The clinical presentation of decreased pain, temperature, and vibration sensation in a patient with a family history is typical for HSAN type I. The progression is usually insidious with distal sensory loss, often accompanied by motor weakness in later stages. It is important to differentiate this from other hereditary neuropathies that might affect different sensory modalities or have additional autonomic features. The differential diagnosis includes diabetic neuropathy, vitamin B12 deficiency neuropathy, and other hereditary neuropathies such as HSAN IV (associated with NTRK1 mutations, which presents with congenital insensitivity to pain and anhidrosis) and familial dysautonomia (HSAN III linked to ELP1 mutations). Genetic testing confirming SPTLC mutations is key to establishing the diagnosis. There is currently no cure for HSAN type I. Management is primarily supportive and includes pain control, physical therapy, and close monitoring for complications such as foot ulcers or infections. Genetic counseling is recommended for affected individuals and their families. In pregnancy and lactation, care should be taken with neuropathic pain medications; drugs like gabapentin may be considered after evaluating risk\u2013benefit ratios and in consultation with specialists. \u2022 Option A (RET): RET mutations are associated with conditions like multiple endocrine neoplasia type 2 and Hirschsprung disease, not HSAN type I. \n\u2022 Option B (SPTLC): This is correct as mutations in the SPTLC genes are the established cause of HSAN type I. \n\u2022 Option C (TRKA): Mutations in the NTRK1 gene, which encodes the TRKA receptor, cause congenital insensitivity to pain with anhidrosis (HSAN IV), a condition distinguishable by its early onset and lack of motor involvement. \n\u2022 Option D (IKAP): Mutations in the ELP1 gene (IKAP) cause familial dysautonomia (HSAN III), which primarily features autonomic dysfunction and has a distinct ethnic prevalence. 1. HSAN type I should be suspected in adults with a family history and a constellation of sensory deficits (pain, temperature, vibration) along with motor involvement. 2. SPTLC mutations lead to toxic deoxysphingolipid accumulation causing axonal damage. Recent research has focused on the role of deoxysphingolipids in the neurodegenerative process of HSAN type I and has even explored the potential therapeutic use of L-serine supplementation. Genetic advances have further refined the classification of hereditary neuropathies and have improved genetic counseling and diagnostic precision in affected families.",
    "exam_year": "2022",
    "exam_type": "Part II"
  }
]